Stock listing

CYP Stock Price, News, Filings & Events — Cynata Therapeutics Limited

Selected listing: CYP · ASX · AUD · AU

CYP:ASX is the public listing for Cynata Therapeutics Limited, a company dedicated to advancing innovative cell therapy solutions. With a market capitalization of approximately AUD 2.2 million, Cynata leverages its proprietary Cymerus technology to produce large quantities of therapeutic cells. The company is actively involved in research and development to enhance its offerings in the cell therapy space, contributing to advancements in medical treatments. Recent news and filings may provide further insights into its ongoing projects and market developments.

CYP:ASXAUDAUUpdated July 24, 2026
Cynata Therapeutics Limited logo
Ticker
CYP:ASX
Asset type
Stock
Market cap
$2.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

Cynata Therapeutics Limited CYP:ASX stock context

CYP:ASX is the public listing for Cynata Therapeutics Limited, a company dedicated to advancing innovative cell therapy solutions. With a market capitalization of approximately AUD 2.2 million, Cynata leverages its proprietary Cymerus technology to produce large quantities of therapeutic cells. The company is actively involved in research and development to enhance its offerings in the cell therapy space, contributing to advancements in medical treatments. Recent news and filings may provide further insights into its ongoing projects and market developments.

Research Cynata Therapeutics Limited

Alternate listings